AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Nexglipt MF 50/500 Tablet

Prescription Icon
Prescription Required

Marketer

Mexican Wave Pharma

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Nexglipt MF 50/500 Tablet

Diabex Duo 50/500mg tablets combine two medications to effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate severe diabetic complications, including kidney impairment and vision loss, and may lessen the risk of cardiovascular events like heart attacks and strokes. Diabex Duo 50/500mg may be used independently or in conjunction with other anti-diabetic therapies. Optimal results are achieved when combined with a balanced diet and regular physical activity. Dosage is tailored to individual needs, considering existing health conditions, glucose levels, and concurrent medications. Consuming the tablet with food minimizes gastrointestinal discomfort. Consistent daily administration at the same time maximizes therapeutic benefits; discontinuation should only occur under medical guidance. Effective blood sugar control helps prevent future health problems. Adherence to the prescribed diet and exercise regimen is crucial. Lifestyle choices are integral to diabetes management. Commonly reported side effects include nausea, diarrhea, vomiting, indigestion, headache, pharyngitis, fatigue, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential adverse effect, particularly when used with insulin or sulfonylureas; patients should be educated on its recognition and management. This medication is not universally suitable. Prior to commencing treatment, disclose any history of kidney, liver, or heart disease, pancreatic disorders, or significant alcohol consumption to your physician. Pregnant or lactating individuals should consult their doctor before use. Potential drug interactions exist; inform your doctor of all medications being taken to ensure safety. Alcohol consumption should be minimized due to its potential to lower blood glucose. Your physician will monitor kidney function and blood glucose levels throughout treatment.

Uses of Nexglipt MF 50/500 Tablet

Managing type 2 diabetes

Major Benefits of Nexglipt MF 50/500 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Nexglipt MF 50/500 Tablet with a meal.

Common Side effects of Nexglipt MF 50/500 Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Nexglipt MF 50/500 Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Nexglipt MF 50/500 Tablet should be administered with a meal.

How Nexglipt MF 50/500 Tablet works:

The dual-action tablet, Nexglipt MF 50/500, combines two distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol and Nexglipt MF 50/500 Tablet should not be consumed together due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Nexglipt MF 50/500 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Nexglipt MF 50/500 tablets while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Nexglipt MF 50/500 Tablets cautiously, as dosage modification may be necessary. Physician consultation is recommended.

LiverLiverUNSAFE

Patients with liver impairment should likely avoid Nexglipt MF 50/500 Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Nexglipt MF 50/500 Tablet :

Should you forget a Nexglipt MF 50/500 Tablet dose, take it immediately if remembered. Otherwise, omit the missed dose if your next scheduled dose is imminent and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Nexglipt MF 50/500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Nexglipt MF 50/500 Tablet

Nexglipt MF 50/500 Tablets rarely cause hypoglycemia by themselves; however, insufficient caloric intake while using this medication may lead to low blood sugar. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness may indicate hypoglycemia, particularly if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Regular blood sugar monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is advisable.
Nausea and vomiting are possible side effects of Nexglipt MF 50/500 Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not self-medicate.
Nexglipt MF 50/500 Tablet is contraindicated in patients with allergies to its components or excipients, and should not be used by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Nexglipt MF 50/500 Tablet combines the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is unsuitable for individuals under 18.
Nexglipt MF 50/500 Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Nexglipt MF 50/500 Tablets and seek immediate medical attention.
Prolonged use of Nexglipt MF 50/500 Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Nexglipt MF 50/500 Tablet is safe when used as directed by your doctor. However, even with proper dosage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and hypoglycemia (low blood sugar, especially if also taking insulin or sulphonylurea) may occur. Report any persistent side effects to your doctor.
Nexglipt MF 50/500 Tablet
82
MRP 100
18% off